ISSN 2619-9734
Contact Us
TR
Toggle navigation
Home
Current Issue
Archive
For Authors
Submit a Manuscript
Journal Info
About the Journal
Editorial Board
Bibliographic Details
Abstracting and Indexing
Publisher
Online Services
Contact Information
Volume:
3
Issue:
2
Year:
2020
3 (2)
Current Issue
Ahead of Print
Archive
Popular Articles
Copyright Transfer Form
Conflict of Interest Form
Submit a Manuscript
Quick Search
In authors and institutes
In titles and abstracts
In all
Updates in Cardiology of the Turkish Society of Cardiology
Most Accessed Articles - UPDATES IN CARDIOLOGY OF THE TURKISH SOCIETY OF CARDIOLOGY
Most Accessed Articles
1.
Pharmacological properties of nebivolol
Ipek Komşuoğlu Çelikyurt
doi:
10.5543/ucard.2019.21931
2019; 2 - 1
|
Pages 7 - 14
Abstract
|
Full Text PDF
REVIEW
2.
Guide on advanced heart failure
Sanem Nalbantgil,
Yüksel Çavuşoğlu
, Bahri Akdeniz, Hakan Altay, Ahmet Çelik, Çağatay Engin, Tolga Sinan Güvenç, Bülent Mutlu, Gökçen Orhan, Bülent Özin, Ahmet Temizhan, Dilek Ural, Nesligül Yıldırım, Mehmet Birhan Yılmaz
doi:
10.5543/ucard.2018.43153
2018; 1 - 1
|
Pages 1 - 79
Abstract
|
Full Text PDF
3.
2017 ESC/EACTS Guidelines for the management of valvular heart disease
Helmut Baumgartner
, Volkmar Falk, Jeroen J. Bax, Michele De Bonis, Christian Hamm, Per Johan Holm, Bernard Iung, Patrizio Lancellotti, Emmanuel Lansac, Daniel Rodriguez Munoz, Raphael Rosenhek, Johan Sjögren, Pilar Tornos Mas, Alec Vahanian, Thomas Walther, Olaf Wendler, Stephan Windecker, Jose Luis Zamorano
doi:
10.1093/eurheartj/ehx391
2018; 1 - 2
|
Pages 1 - 53
Abstract
|
Full Text PDF
INVITED REVIEW
4.
Beta-blockers in cardiovascular prevention
Barış Ilerigelen
doi:
10.5543/ucard.2019.00719
2019; 2 - 1
|
Pages 1 - 6
Abstract
|
Full Text PDF
5.
Nebivolol in the treatment of systemic hypertension
Fatih Sinan Ertaş
doi:
10.5543/ucard.2019.76486
2019; 2 - 1
|
Pages 15 - 19
Abstract
|
Full Text PDF
6.
Approach to secondary prevention patient in the 2019 European Society of Cardiology Dyslipidemia Guide
Meral Kayıkçıoğlu
doi:
10.5543/ucard.2019.98608
2020; 3 - 1
|
Pages 7 - 9
Abstract
|
Full Text PDF
7.
Clinical trials with nebivolol in Turkey
Mustafa Kılıçkap
doi:
10.5543/ucard.2019.66375
2019; 2 - 1
|
Pages 25 - 30
Abstract
|
Full Text PDF
8.
Nebivolol in heart failure teatment
Ahmet Temizhan
doi:
10.5543/ucard.2019.33042
2019; 2 - 1
|
Pages 20 - 24
Abstract
|
Full Text PDF
9.
Introduction to 2019 ESC/EAS Guidelines for the Management of Dyslipidema
Lale Tokgözoğlu
doi:
10.5543/ucard.2019.25744
2020; 3 - 1
|
Pages 1 - 2
Abstract
|
Full Text PDF
10.
Diet and lifestyle modifications
Ümit Yaşar Sinan
doi:
10.5543/ucard.2019.02996
2020; 3 - 1
|
Pages 25 - 29
Abstract
|
Full Text PDF
11.
Risk scoring and primary prevention
Öner Özdoğan
doi:
10.5543/ucard.2019.69188
2020; 3 - 1
|
Pages 3 - 6
Abstract
|
Full Text PDF
EDITORIAL
12.
Editorial
Sanem Nalbantgil
, Yüksel Çavuşoğlu
2018; 1 - 1
|
Page I
DOWNLOAD
13.
Lipid therapy in young and elderly
Ceyhun Ceyhan
, Fatih Sivri
doi:
10.5543/ucard.2019.65375
2020; 3 - 1
|
Pages 16 - 19
Abstract
|
Full Text PDF
14.
Statin intolerance
Özcan Başaran
doi:
10.5543/ucard.2019.09719
2020; 3 - 1
|
Pages 20 - 24
Abstract
|
Full Text PDF
15.
Lipid lowering therapy in particular patient populations
Barış Güngör
doi:
10.5543/ucard.2019.09797
2020; 3 - 1
|
Pages 10 - 15
Abstract
|
Full Text PDF
16.
Editorial
Öner Özdoğan
2020; 3 - 1
|
Page I
DOWNLOAD
REVIEW
17.
Sakubitril/valsartan’ın yaşa göre etkinlik ve güvenliğinde fark olur mu?
Rezzan Deniz Acar
doi:
10.5543/ucard.2020.63835
2020; 3 - 2
|
Pages 42 - 44
Abstract
|
Full Text PDF
18.
Sakubitril/valsartan’ın miyokardiyal biyobelirteçler (BNP, NTproBNP, kardiyak troponin, ST2, vs) üzerine etkisi nasıldır?
Tolga Sinan Güvenç
doi:
10.5543/ucard.2020.46220
2020; 3 - 2
|
Pages 98 - 101
Abstract
|
Full Text PDF
19.
Klinik uygulamada sakubitril/valsartan’a ilişkin dikkat edilmesi gereken yan etkiler nelerdir?
Meryem Aktoz
, Gökay Taylan
doi:
10.5543/ucard.2020.08370
2020; 3 - 2
|
Pages 25 - 27
Abstract
|
Full Text PDF
20.
Sakubitril/valsartan’ın kalp yetersizliğinde yarar sağlayan etki mekanizmaları nelerdir?
Lütfü Bekar
doi:
10.5543/ucard.2020.92485
2020; 3 - 2
|
Pages 1 - 3
Abstract
|
Full Text PDF
© Copyright 2021 Updates in Cardiology of the Turkish Society of Cardiology
Contact Us
Home Page
LookUs
&
Online Makale